SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 114 filers reported holding SEELOS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,498 | -83.8% | 13,577 | +4.9% | 0.00% | – |
| Q2 2023 | $15,460 | +92.0% | 12,937 | +11.1% | 0.00% | – |
| Q1 2023 | $8,050 | +0.9% | 11,646 | -0.8% | 0.00% | – |
| Q4 2022 | $7,975 | -33.5% | 11,745 | -0.0% | 0.00% | – |
| Q3 2022 | $12,000 | +20.0% | 11,749 | -16.1% | 0.00% | – |
| Q2 2022 | $10,000 | +25.0% | 14,010 | +2.9% | 0.00% | – |
| Q1 2022 | $8,000 | -65.2% | 13,614 | -5.1% | 0.00% | – |
| Q4 2021 | $23,000 | -36.1% | 14,353 | -3.6% | 0.00% | – |
| Q3 2021 | $36,000 | -12.2% | 14,887 | -3.4% | 0.00% | – |
| Q2 2021 | $41,000 | -24.1% | 15,413 | +43.1% | 0.00% | – |
| Q1 2021 | $54,000 | +800.0% | 10,770 | -20.1% | 0.00% | – |
| Q1 2020 | $6,000 | +100.0% | 13,476 | +366.5% | 0.00% | – |
| Q3 2019 | $3,000 | – | 2,889 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,500,000 | $4,075,000 | 1.71% |
| Connacht Asset Management LP | 498,925 | $813,000 | 0.79% |
| GENDELL JEFFREY L | 2,449,267 | $3,992,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 2,133,436 | $3,478,000 | 0.21% |
| Uniplan Investment Counsel, Inc. | 1,550,359 | $2,527,000 | 0.14% |
| Financial Advocates Investment Management | 24,673 | $1,994,000 | 0.13% |
| Connacht Asset Management LP | 72,300 | $118,000 | 0.12% |
| Woodline Partners LP | 4,047,231 | $6,597,000 | 0.09% |
| 1492 Capital Management LLC | 108,286 | $177,000 | 0.09% |
| Ikarian Capital, LLC | 244,171 | $398,000 | 0.06% |